Efficacy of single-agent bortezomib vs. single-agent thalidomide in patients with relapsed or refractory multiple myeloma: a systematic comparison

Efficacy of single-agent bortezomib vs. single-agent thalidomide in patients with relapsed or refractory multiple myeloma: a systematic comparison

Bibliographic Details
Main Authors: Prince, H Miles, Adena, Michael, Smith, Dell Kingsford, Hertel, Judy
Format: Online
Language:English
Published: Blackwell Publishing Ltd 2007
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1974816/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1974816/

Similar Items